Response and long-term control of bone metastases after peptide receptor radionuclide therapy with 177Lu-octreotate

被引：0
|
作者：
Ezziddin, S. [1 ]
Sabet, A. [1 ]
Heinemann, F. [1 ]
Yong-Hing, C. [2 ]
Ahmadzadehfar, H. [1 ]
Guhlke, S. [1 ]
Hoeller, T. [1 ]
Willinek, W. [1 ]
Boy, C. [3 ]
Biersack, H. [1 ]
机构：
[1] Univ Hosp, Bonn, Germany
[2] Univ British Columbia Hosp, Vancouver, BC, Canada
[3] Univ Hosp, Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
    Ezziddin, Samer
    Sabet, Amir
    Heinemann, Florian
    Yong-Hing, Charlotte J.
    Ahmadzadehfar, Hojjat
    Guhlke, Stefan
    Hoeller, Tobias
    Willinek, Winfried
    Boy, Christian
    Biersack, Hans-Juergen
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (08) : 1197 - 1203
  • [2] Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
    Sabet, Amir
    Ezziddin, Khaled
    Pape, Ulrich-Frank
    Ahmadzadehfar, Hojjat
    Mayer, Karin
    Poeppel, Thorsten
    Guhlke, Stefan
    Biersack, Hans-Juergen
    Ezziddin, Samer
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1857 - 1861
  • [3] Response and long-term control of bone metastases after peptide receptor radionuclide therapy with Lu177-DOTA octreotate
    Ezziddin, Samer
    Sabet, Amir
    Heinemann, Florian
    Yong-Hing, Charlotte
    Ahmadzadehfar, Hojjat
    Guhlke, Stefan
    Hoeller, Tobias
    Willinek, Winfried
    Biersack, Hans
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [4] Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate
    Amir Sabet
    Khaled Ezziddin
    Ulrich-Frank Pape
    Karl Reichman
    Torjan Haslerud
    Hojjat Ahmadzadehfar
    Hans-Jürgen Biersack
    James Nagarajah
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 505 - 510
  • [5] Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate
    Sabet, Amir
    Ezziddin, Khaled
    Pape, Ulrich-Frank
    Reichman, Karl
    Haslerud, Torjan
    Ahmadzadehfar, Hojjat
    Biersack, Hans-Juergen
    Nagarajah, James
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (03) : 505 - 510
  • [6] Peptide receptor radionuclide therapy with 177Lu-octreotate in foregut carcinoid tumours
    Van Essen, M.
    Krenning, E. P.
    Bakker, W. H.
    Kooij, P. P.
    Kwekkeboom, D. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S215 - S215
  • [7] Accurate assessment of long-term nephrotoxicity after therapy with 177Lu-octreotate
    Sabet, A.
    Ezziddin, K.
    Reichmann, K.
    Ahmadzadehfar, H.
    Haslerud, T.
    Guhlke, S.
    Biersack, H.
    Ezziddin, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S333 - S333
  • [8] Long-term survival and toxicity in patients with neuroendocrine tumors treated with 177Lu-octreotate peptide radionuclide therapy
    Ransom, D.
    Kennedy, K.
    Turner, J.
    Macdonald, W.
    Boardman, G.
    Claringbold, P.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 205 - 205
  • [9] Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma
    Schneider, Julia R.
    Shatzkes, Deborah R.
    Scharf, Stephen C.
    Tham, Tristan M.
    Kulason, Kay O.
    Buteau, Francois-Alexandre
    Del Prete, Michela
    Chakraborty, Shamik
    Anderson, Todd A.
    Asiry, Saeed
    Beauregard, Jean-Mathieu
    Langer, David J.
    Costantino, Peter D.
    Boockvar, John A.
    OPERATIVE NEUROSURGERY, 2018, 15 (06) : E100 - E109
  • [10] Accurate assessment of long-term nephrotoxicity after therapy with 177Lu-octreotate
    Sabet, Amir
    Ezziddin, Khaled
    Reichmann, Karl
    Ahmadzadehfar, Hojjat
    Haslerud, Torjan
    Guhlke, Stefan
    Biersack, Hans Juergen
    Ezziddin, Samer
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345